Eva Ehrnrooth's most recent trade in IO Biotech Inc was a trade of 120,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 20, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| IO Biotech Inc | Eva Ehrnrooth | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) |